Skip to content
DeepViews

Warby Parker Inc. (WRBY) — Analysis Summary

Warby Parker Inc. (WRBY) has a market cap of $3.21B with year-over-year revenue growth of +13.0%. Net margin stands at 0.2%. The stock trades at a P/E ratio of 415.0.

Key Takeaways

  • Revenue changed +13.0% year-over-year
  • Net margin of 0.2%
  • P/E ratio of 415.0

Compared to other companies in the OPHTHALMIC GOODS sector, WRBY posted revenue growth of +13.0% and trades at a P/E of 415.0.

[XNYS]

Warby Parker Inc. (WRBY)

$25.99

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$3212.57M
Enterprise Value
$2919.90M
P/E Ratio
415.0
Div Yield
0.00%
EV/EBITDA
53.1
Company Profile
About
About Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Sector

OPHTHALMIC GOODS

Employees

4,036

Headquarters

NEW YORK, NY

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
58
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$391.99M
Total Debt$0.00M
Debt-to-Equity0.00
Cash & Equivalents$292.67M

Cash Flow

Operating Cash Flow$95.36M
Free Cash Flow$21.75M
FCF Margin2.39%
P/FCF Ratio147.73
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.